Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Heteroaryl heterocyclyl compounds for the treatment of autoimmune disease

Heteroaryl heterocyclyl compounds for the treatment of autoimmune disease

US Patent 11713327 · Granted Aug 1, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Triazatricycle compounds for the treatment of autoimmune disease2025
Hydro-1H-pyrrolo[1,2-a]pyrazine compounds for the treatment of autoimmune diseas2025
Hydropyrido[1,2-α]pyrazine compounds for the treatment of autoimmune disease2025
Hydropyrido[1,2-α]pyrazine compounds for the treatment of autoimmune disease2025
Hydropyrido[1,2-α]pyrazine compounds for the treatment of autoimmune disease2025
Hydropyrazino[1,2-d][1,4]diazepine compounds for the treatment of autoimmune dis2025
Hydropyrazino[1,2-d][1,4]diazepine compounds for the treatment of autoimmune dis2025
Spiro (isobenzofuranazetidine) compounds for the treatment of autoimmune disease2025
Spiro (isobenzofuranazetidine) compounds for the treatment of autoimmune disease2025
Spiro (isobenzofuranazetidine) compounds for the treatment of autoimmune disease2025
Driving method and apparatus for light-emitting substrate, and driving chip and 2025
URL parameter value anomaly detection method and system for the same2025